# Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma

> **NCT00373347** · — · COMPLETED · sponsor: **Stanford University** · enrollment: 573 (actual)

## Conditions studied

- Liver Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00373347
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2024-11-18
- **Final completion:** 2024-11-18
- **Target enrollment:** 573 (ACTUAL)
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00373347

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00373347, "Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00373347. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*